Today's Top Reads

Today's Top Reads

From Doctor to Researcher: Meet a Woman Who's Spent Much of Her Career Fighting Prostate Cancer
Meet the First Female Scientist Johnson & Johnson Ever Hired
Clinical Trials 2.0: 5 Ways Johnson & Johnson Is Helping Revamp—and Revolutionize—How They're Conducted

Graphic featuring a syringe to illustrate an HIV vaccine trial

Share

Innovation

Innovation-opedia: What Is a Mosaic Vaccine?

Share

As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.

By Johnson & JohnsonJuly 22, 2019

expand

Illustrated handwritten definition of a mosaic HIV vaccine

expand

Illustration of a microscope with information about Janssen Vaccines & Prevention B.V. investigational HIV-1 vaccine regimen

The Quest for a Global Preventive HIV Vaccine Reaches an Exciting Milestone With the Mosaico Study

expand

expand

Illustration of the # 4 explaining how many injections would be administered for Janssen’s investigational HIV-1 vaccine.

expand

expand

Illustration showing location of the IAS Conference on HIV Science with details about Janssen’s new Mosaico clinical trial.

expand

Illustrated quote by Janssen’s Maria Grazia Pau talking about the goal of creating a global HIV vaccine.

We’re Committed to Helping Lead the Fight Against HIV/AIDS

Read about the many ways Johnson & Johnson is working to #makeHIVhistory.

Learn more